Hermetica Superfood Encyclopedia
The Short Answer
Polyscias scutellaria contains phenolic compounds (14.67 ± 0.33 mg GAE/g in 96% ethanol extract), flavonoids including quercetin, kaempferol, and rutin, plus oleanane-type saponins such as Polysciasaponin P1 and P3, which exert antioxidant, anti-inflammatory, and putative lactogenic effects through free-radical scavenging and dopamine D2 receptor modulation. The most clinically discussed application is supporting breast-milk production in lactating mothers, with in silico docking studies identifying kaempferol, myricetin, and quercetin as dopamine D2 receptor inhibitors that may disinhibit prolactin secretion, though no randomized controlled trial data currently quantify effect size in humans.
CategoryHerb
GroupPacific Islands
Evidence LevelPreliminary
Primary KeywordTongan Kakala benefits
Tongan Kakala — botanical close-up
Health Benefits
**Lactogenic Support**
Flavonoids kaempferol, myricetin, and quercetin have been identified via molecular docking as dopamine D2 receptor (D2R) inhibitors; by blocking D2R-mediated dopamine suppression of prolactin, these compounds may promote breast-milk production in lactating mothers.
**Antioxidant Activity**: The 96% ethanol leaf extract contains 14
67 ± 0.33 mg GAE/g total phenolics and 1.83 ± 0.05 mg QE/g flavonoids, demonstrating measurable free-radical scavenging capacity in DPPH assays, which may protect cells from oxidative damage.
**Anti-Inflammatory Effects**
Leaf extracts reduce nitric oxide (NO) production and suppress pro-inflammatory cytokines TNF-α, IL-6, IL-1β, and IL-12 in lipopolysaccharide-stimulated RAW 264.7 macrophage cells, with activity correlated to total phenolic and flavonoid content.
**Antidiabetic Potential**
In vivo studies using Swiss albino mouse models have explored glucose-lowering effects of leaf extracts, with saponins and flavonoids proposed as the active constituents modulating carbohydrate metabolism, though dose-response data in humans are absent.
**Anthelmintic Activity**: Methanol and ethanol extracts of P
scutellaria leaves have demonstrated antiparasitic activity in experimental models, consistent with traditional Pacific Island use against intestinal parasites, attributed in part to saponin-induced membrane disruption in helminths.
**Potential Anticancer Properties**
In silico docking studies show kaempferol, myricetin, and quercetin bind Bcl-2 anti-apoptotic proteins with scores of -5.92, -6.02, and -6.40 kcal/mol respectively, suggesting possible pro-apoptotic activity in cancer cells, pending experimental validation.
**Hypolipidemic and Circulatory Support**
Traditional ethnobotanical records document use of P. scutellaria for improving circulation and managing lipid-related metabolic conditions, with oleanolic acid and its glycosides considered plausible mechanistic contributors based on activity seen in related Polyscias species.
Origin & History
Natural habitat
Polyscias scutellaria, commonly called shield aralia or Tongan Kakala, is native to the Pacific Islands and Southeast Asia, growing widely across Tonga, Fiji, and neighboring archipelagos in tropical and subtropical humid environments. The plant thrives in lowland coastal forests and village gardens, tolerating a range of soils, and is traditionally cultivated near dwellings for ready medicinal and culinary access. Its ornamental, shield-shaped leaves make it a recognizable garden plant throughout Polynesia, Melanesia, and parts of insular Southeast Asia.
“Polyscias scutellaria has been embedded in Pacific Island healing traditions for generations, particularly in Tonga where it carries the culturally resonant name 'Kakala'—a term associated with fragrance and ritual plants used in garlands and ceremonies, reflecting the plant's dual role as ornamental and medicinal. In traditional Tongan and Fijian medicine, the leaves were prepared as infusions or poultices to manage inflammation, promote breast-milk production in new mothers, treat gastrointestinal complaints associated with intestinal worms, and support metabolic health. The plant is also documented in Southeast Asian ethnobotanical records across Indonesia and the Philippines, where related Polyscias species are used for comparable indications including wound healing and fever management, attesting to broad cross-cultural recognition of its medicinal properties. Historical documentation in colonial-era botanical surveys of the Pacific Islands records P. scutellaria as a commonly cultivated household plant, and contemporary ethnobotanical fieldwork continues to identify it as an active component of traditional birth and postpartum care practices in Polynesia.”Traditional Medicine
Scientific Research
The evidence base for Polyscias scutellaria consists entirely of in vitro cell-culture studies, in vivo rodent experiments, in silico molecular docking analyses, and ethnobotanical surveys; no peer-reviewed randomized controlled trials or phase I–III clinical studies have been published as of the latest available data. Anti-inflammatory activity has been characterized in RAW 264.7 macrophage assays with quantified cytokine suppression, and antioxidant capacity has been measured by DPPH, ABTS, and FRAP assays using standardized extracts, providing reproducible phytochemical benchmarks but not clinical efficacy data. Antidiabetic effects were explored in Swiss albino mouse models with oral administration of leaf extracts, and anthelmintic potency was assessed against standard parasite strains in vitro, yet neither study reported sufficient sample sizes or blinding procedures to meet modern preclinical reporting standards. The sole human-relevant reference—improved breast-milk production in lactating mothers—lacks trial registration, sample size, control group, and statistical reporting, rendering it anecdotal rather than evidentiary; the overall body of research therefore reflects early-stage discovery science rather than clinically actionable evidence.
Preparation & Dosage
Traditional preparation
**Traditional Aqueous Decoction**
Fresh or dried leaves are simmered in water and consumed as a tea; no standardized volume or concentration has been established, but ethnobotanical accounts describe 1–2 cups daily for lactation support in Pacific Island communities.
**Ethanol Extract (Research Grade)**
67 mg GAE/g phenolics; no commercial supplement standardized to this specification is currently available
Laboratory studies employ 96% ethanol leaf extracts yielding 14..
**Methanol Extract (Research Grade)**
Used in anthelmintic and antidiabetic in vivo studies; enriched in alkaloids, carbohydrates, and saponins relative to ethanol extracts, but not suitable for human consumption without solvent removal and safety validation.
**Ethyl Acetate Fraction**
Used in in vitro anti-inflammatory assays; represents a mid-polarity fraction enriched in terpenes and flavonoid aglycones.
**Leaf Powder**
Dried leaf powder has been prepared for rodent gavage studies; no human-dose equivalent, bioavailability factor, or standardization percentage has been established.
**Timing and Dose Caution**
No evidence-based dosing schedule exists; traditional use patterns suggest daily consumption during lactation, but without pharmacokinetic data, no minimum effective or maximum safe dose can be recommended.
Nutritional Profile
Polyscias scutellaria leaves contain a complex array of secondary metabolites rather than a nutritionally prominent macronutrient profile; total phenolic content in the 96% ethanol extract is quantified at 14.67 ± 0.33 mg GAE/g dry weight, and total flavonoids at 1.83 ± 0.05 mg QE/g dry weight, placing it in the moderate range for phenolic-rich medicinal leaves. Specific flavonoids identified include quercetin, kaempferol, myricetin (flavonols), luteolin and apigenin (flavones), and the glycosides quercetin-3-O-D-glucoside and rutin; terpenes include oleanolic acid and (-)-caryophyllene oxide, while saponins include Polysciasaponin P1 and P3. Alkaloids and carbohydrates are more abundant in methanol extracts, and sterols and lignans have also been detected across the Polyscias genus in phytochemical screening studies. No data on primary macronutrients (protein, fat, carbohydrate per gram of leaf), mineral content, or vitamin concentrations have been published for this species, and bioavailability of its flavonoid glycosides in humans has not been assessed through pharmacokinetic studies.
How It Works
Mechanism of Action
The lactogenic mechanism centers on flavonoids—principally kaempferol, myricetin, quercetin, and the saponin 3-β-[O-α-L-rhamnopyranosyl-(1→2)-α-arabinopyranosyl)oxy]-16-alpha compound—acting as competitive inhibitors at the dopamine D2 receptor (D2R), thereby reducing dopaminergic inhibition of prolactin release from anterior pituitary lactotrophs; complementary in silico evidence also identifies binding of P. scutellaria extract (PSE) compounds to the serotonin 5-HT2A receptor, which may further modulate prolactin secretion. Anti-inflammatory activity proceeds through suppression of the NF-κB-associated cytokine cascade, with phenolics and flavonoids reducing inducible nitric oxide synthase (iNOS) activity and downstream NO, TNF-α, IL-6, IL-1β, and IL-12 production in activated macrophages. Antioxidant effects are mediated by the electron-donating capacity of hydroxyl groups on the flavonoid B-ring (quercetin, rutin, luteolin, apigenin), enabling direct hydrogen-atom transfer to DPPH and other reactive oxygen species. Saponins, particularly oleanolic glycosides Polysciasaponin P1 and P3, are believed to contribute to anthelmintic and antidiabetic effects through membrane perturbation and modulation of glucose transporter activity, respectively, though these molecular pathways have not been confirmed in human cell lines.
Clinical Evidence
No formal clinical trials with registered protocols, defined sample sizes, randomization, or reported confidence intervals have investigated Polyscias scutellaria in human subjects for any indication, including infant colic relief or lactation support. The closest human-oriented data is an uncontrolled observational report of improved breast-milk production in lactating mothers consuming the plant, without quantification of milk volume, prolactin levels, or infant outcomes. Preclinical models provide mechanistic plausibility for anti-inflammatory, antioxidant, antidiabetic, and lactogenic activities, but effect sizes, optimal doses, and safety margins in humans remain undefined. Confidence in therapeutic outcomes is therefore very low; clinicians should regard current findings as hypothesis-generating rather than practice-informing until properly designed human trials are conducted.
Safety & Interactions
In vivo toxicological evaluation of the methanol extract of P. scutellaria leaves (MEPSL) in rodent models indicated moderate toxicity, suggesting a meaningful safety margin exists but that high doses carry hepatic or systemic risk; the specific LD50 value was not reported in publicly available results, and no human maximum tolerated dose has been established. Saponins present in the extract are known as a chemical class to cause gastrointestinal irritation, hemolysis at high concentrations, and altered intestinal permeability, making high-dose or prolonged use potentially problematic without further safety characterization. No formal drug interaction studies have been performed; however, the dopamine D2 receptor inhibitory activity of constituent flavonoids raises a theoretical concern for interaction with dopaminergic medications such as antipsychotics (haloperidol, risperidone), dopamine agonists used in Parkinson's disease (levodopa, pramipexole), and prolactin-suppressing drugs (cabergoline, bromocriptine). Pregnancy safety has not been evaluated; while the plant is traditionally used postpartum for lactation, its use during pregnancy, in infants with colic (the stated primary use), and in individuals with hormone-sensitive conditions should be approached with extreme caution until clinical safety data are available.
Synergy Stack
Hermetica Formulation Heuristic
Also Known As
Polyscias scutellariaShield araliaKakalaPlum araliaNothopanax scutellarius
Frequently Asked Questions
Can Tongan Kakala help with infant colic?
There is no direct clinical evidence that Polyscias scutellaria relieves infant colic; its traditional Pacific Island use for this indication is anecdotal and no human trials have been conducted. The plant's anti-inflammatory flavonoids (quercetin, kaempferol) and saponins might theoretically reduce intestinal inflammation, but without safety data in infants, administration to newborns or young babies cannot be recommended until rigorous pediatric studies are completed.
How does Tongan Kakala support breast milk production?
Molecular docking studies identify kaempferol, myricetin, quercetin, and an oleanane saponin in Polyscias scutellaria as inhibitors of the dopamine D2 receptor (D2R); by blocking D2R, these compounds may reduce dopamine's suppression of prolactin release from the pituitary, thereby increasing milk production. Complementary in silico analysis also suggests binding to the serotonin 5-HT2A receptor, but human clinical trial confirmation of these mechanisms and their practical magnitude is not yet available.
Is Polyscias scutellaria safe to use during breastfeeding?
Polyscias scutellaria has been used traditionally by lactating mothers in Tonga and Fiji, and it is generally considered a galactagogue in Pacific Island folk medicine; however, an in vivo rodent study noted moderate toxicity for the methanol leaf extract, and no human pharmacokinetic or safety trials have been completed. Until formal safety studies establish a tolerable dose and confirm the absence of transfer of toxic constituents to breast milk, use should be approached cautiously and ideally under the guidance of a qualified healthcare provider.
What bioactive compounds are in Polyscias scutellaria?
The leaves of Polyscias scutellaria contain total phenolics at 14.67 ± 0.33 mg GAE/g and flavonoids at 1.83 ± 0.05 mg QE/g in 96% ethanol extracts, with specific compounds including quercetin, kaempferol, myricetin, luteolin, apigenin, rutin, and quercetin-3-O-D-glucoside. The plant also contains oleanolic acid, (-)-caryophyllene oxide, the saponins Polysciasaponin P1 and P3, alkaloids, and lignans, making its phytochemical profile broadly representative of the Araliaceae family.
Does Tongan Kakala have anti-inflammatory properties?
Yes, laboratory studies using RAW 264.7 macrophage cells stimulated with lipopolysaccharide show that P. scutellaria leaf extracts reduce nitric oxide production and lower pro-inflammatory cytokines TNF-α, IL-6, IL-1β, and IL-12, with activity correlating to total phenolic and flavonoid content. These findings are based on in vitro data only; no clinical trials in humans with inflammatory conditions have been conducted, so the magnitude of anti-inflammatory benefit in a living person remains uncertain.
What is the recommended dosage of Tongan Kakala for lactation support?
Clinical dosage guidelines for Tongan Kakala have not been standardized in peer-reviewed literature, as most traditional use involves whole-plant preparations rather than isolated extracts. Traditional Tongan preparations typically use fresh or dried leaves in herbal infusions, but modern supplement doses vary widely by manufacturer. Consulting with a healthcare provider familiar with traditional Pacific Island herbs is recommended to establish appropriate dosing for individual circumstances.
Are there any drug interactions between Tongan Kakala and antidepressants or dopamine-related medications?
Tongan Kakala's flavonoids may interact with medications that affect dopamine signaling or prolactin regulation, including antipsychotics, metoclopramide, and some antidepressants. Since the herb appears to modulate dopamine D2 receptor activity through molecular mechanisms, concurrent use with these medications should be discussed with a healthcare provider beforehand. Limited clinical data exists on specific interactions, making professional medical oversight essential before combining Tongan Kakala with prescription drugs.
How does Tongan Kakala compare to other traditional lactogenic herbs like fenugreek or blessed thistle?
Tongan Kakala contains documented flavonoids (kaempferol, myricetin, quercetin) with theoretical D2R-inhibitory activity, whereas fenugreek and blessed thistle rely on different phytochemical mechanisms and have more extensive clinical research supporting their lactogenic effects. While all three are used traditionally to support milk production, Polyscias scutellaria has significantly less clinical validation in modern studies compared to these better-researched alternatives. The choice between them may depend on cultural background, local availability, and individual response, though fenugreek and blessed thistle have more robust evidence bases.
Explore the Full Encyclopedia
7,400+ ingredients researched, verified, and formulated for optimal synergy.
Browse IngredientsThese statements have not been evaluated by the Food and Drug Administration. This content is for informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease.
hermetica-encyclopedia-canary-zzqv9k4w tongan-kakala-polyscias-scutellaria curated by Hermetica Superfoods at ingredients.hermeticasuperfoods.com and licensed CC BY-NC-SA 4.0 (non-commercial share-alike, attribution required)
